Overview

Ruxolitinib Cream in the Treatment of Cutaneous Necrobiosis Lipoidica

Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
This research study is evaluating the safety and efficacy of a topical drug treatment "Ruxolitinib" in treating Necrobiosis Lipoidica (NL).
Phase:
Phase 2
Details
Lead Sponsor:
Aaron R. Mangold